Drug Enforcement Administration April 2007 – Federal Register Recent Federal Regulation Documents

Importer of Controlled Substances Notice of Application
Document Number: E7-8133
Type: Notice
Date: 2007-04-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Notice of Application
Document Number: E7-8132
Type: Notice
Date: 2007-04-30
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application
Document Number: E7-8131
Type: Notice
Date: 2007-04-30
Agency: Drug Enforcement Administration, Department of Justice
Control of a Chemical Precursor Used in the Illicit Manufacture of Fentanyl as a List I Chemical
Document Number: 07-2015
Type: Rule
Date: 2007-04-23
Agency: Drug Enforcement Administration, Department of Justice
This rulemaking controls the chemical N-phenethyl-4-piperidone (NPP) as a List I chemical under the Controlled Substances Act (CSA) (21 U.S.C. 801 et seq.). Clandestine laboratories are using this chemical to illicitly manufacture the schedule II controlled substance fentanyl. The recent distribution of illicitly manufactured fentanyl has caused an unprecedented outbreak of hundreds of suspected fentanyl- related overdoses, at least 972 confirmed fentanyl-related deaths, and 162 suspected fentanyl-related deaths occurring mostly in Delaware, Illinois, Maryland, Michigan, Missouri, New Jersey, and Pennsylvania. NPP has been identified as the starting material in several seized fentanyl clandestine laboratories. In addition to DEA's concern regarding the deaths associated with illicitly manufactured fentanyl, DEA is extremely concerned about the safety of law enforcement officers encountering these clandestine laboratories. Therefore, DEA is regulating NPP as a List I chemical through this Interim Rulemaking. DEA is soliciting comments on this Interim Rule. This rulemaking will subject handlers of NPP to the chemical regulatory provisions of the CSA and its implementing regulations, including 21 CFR Parts 1309, 1310, 1313, and 1316. This rulemaking does not establish a threshold for domestic and international transactions of NPP. As such, all transactions involving NPP, regardless of size, shall be regulated. This rulemaking also specifies that chemical mixtures containing NPP will not be exempt from regulatory requirements at any concentration. Therefore, all transactions of chemical mixtures containing any quantity of NPP will be regulated and will be subject to control under the CSA.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E7-7080
Type: Notice
Date: 2007-04-13
Agency: Drug Enforcement Administration, Department of Justice
Piyush V. Patel, M.D.; Revocation of Registration
Document Number: E7-6761
Type: Notice
Date: 2007-04-11
Agency: Drug Enforcement Administration, Department of Justice
Bourne Pharmacy, Inc.; Revocation of Registration
Document Number: E7-6760
Type: Notice
Date: 2007-04-11
Agency: Drug Enforcement Administration, Department of Justice
Rick's Picks, L.L.C.; Revocation of Registration
Document Number: E7-6759
Type: Notice
Date: 2007-04-11
Agency: Drug Enforcement Administration, Department of Justice
Implementation of the Combat Methamphetamine Epidemic Act of 2005; Notice of Transfers Following Importation or Exportation
Document Number: 07-1718
Type: Rule
Date: 2007-04-09
Agency: Drug Enforcement Administration, Department of Justice
This regulation implements section 716 of the Combat Methamphetamine Epidemic Act (CMEA) of 2005 (21 U.S.C. 971 as amended), which was enacted on March 9, 2006. DEA is amending its regulations to require additional reporting for import, export, and international transactions involving all List I and List II chemicals. This rule implements section 716 of the CMEA which extends current reporting requirements for importations, exportations, and international transactions involving List I and List II chemicals.